Having emerged from stealth in October 2025 with a seed round of $21m, Irish RNA biotech Aerska has raised a $39m series A funding round.
Read more: Irish biotech Aerska raises $39m Series A to deliver RNA meds to the brain
•
Having emerged from stealth in October 2025 with a seed round of $21m, Irish RNA biotech Aerska has raised a $39m series A funding round.
Read more: Irish biotech Aerska raises $39m Series A to deliver RNA meds to the brain